Arcellx (ACLX) News Today $62.44 -4.79 (-7.12%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$62.82 +0.38 (+0.61%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Arcellx (NASDAQ:ACLX) Shares Down 7.7% - Time to Sell?Arcellx (NASDAQ:ACLX) Shares Down 7.7% - Time to Sell?April 1 at 3:31 PM | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Shares Sold by NEOS Investment Management LLCNEOS Investment Management LLC lowered its holdings in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 37.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,468 shares of the company's stock after selling 4,442 sharApril 1 at 4:14 AM | marketbeat.comThrivent Financial for Lutherans Has $5.33 Million Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX)Thrivent Financial for Lutherans increased its position in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 44.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 69,461 shares of the company's stock after pMarch 25, 2025 | marketbeat.comCibc World Markets Corp Takes Position in Arcellx, Inc. (NASDAQ:ACLX)Cibc World Markets Corp acquired a new position in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 4,033 shares of the company's stock, valued at approxiMarch 25, 2025 | marketbeat.comIntech Investment Management LLC Raises Holdings in Arcellx, Inc. (NASDAQ:ACLX)Intech Investment Management LLC boosted its stake in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 79.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,207 shares of the company's stock after acquiring an additiMarch 23, 2025 | marketbeat.comRaymond James Financial Inc. Acquires New Position in Arcellx, Inc. (NASDAQ:ACLX)Raymond James Financial Inc. acquired a new stake in Arcellx, Inc. (NASDAQ:ACLX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 130,601 shares of the company's stock, valued at approximately $10,016,000. RaymoMarch 22, 2025 | marketbeat.comArcellx Appoints Andrew Galligan and Kristin Myers to Its Board of DirectorsMarch 20, 2025 | businesswire.comArcellx, Inc. (NASDAQ:ACLX) Director Sells $107,460.00 in StockArcellx, Inc. (NASDAQ:ACLX - Get Free Report) Director Kavita Patel sold 1,500 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $71.64, for a total transaction of $107,460.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.March 19, 2025 | marketbeat.comArcellx CMO Discusses Novel Investigational CAR-T Therapy During Multiple Myeloma Awareness MonthMarch 18, 2025 | globenewswire.comCharles Schwab Investment Management Inc. Buys 14,992 Shares of Arcellx, Inc. (NASDAQ:ACLX)Charles Schwab Investment Management Inc. boosted its stake in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 4.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 343,085 shares of the company's stock after purchasMarch 18, 2025 | marketbeat.comArcellx Impressive Safety Data Leaves DoubtsMarch 17, 2025 | seekingalpha.comACLX June 20th Options Begin TradingMarch 14, 2025 | nasdaq.comBank of New York Mellon Corp Buys 27,350 Shares of Arcellx, Inc. (NASDAQ:ACLX)Bank of New York Mellon Corp raised its stake in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 23.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 144,409 shares of the company's stock after buying an additional 27,350 sharMarch 14, 2025 | marketbeat.comVictory Capital Management Inc. Has $14.13 Million Stake in Arcellx, Inc. (NASDAQ:ACLX)Victory Capital Management Inc. reduced its position in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 19.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 184,183 shares of the company'March 13, 2025 | marketbeat.comArcellx (NASDAQ:ACLX) Shares Gap Up - Here's What HappenedArcellx (NASDAQ:ACLX) Shares Gap Up - Should You Buy?March 8, 2025 | marketbeat.comJackson Creek Investment Advisors LLC Buys New Shares in Arcellx, Inc. (NASDAQ:ACLX)Jackson Creek Investment Advisors LLC bought a new position in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 15,389 shares of the company's stock, valued at approximately $1,180,000. Other large invMarch 8, 2025 | marketbeat.comCandriam S.C.A. Sells 45,367 Shares of Arcellx, Inc. (NASDAQ:ACLX)Candriam S.C.A. lessened its stake in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 18.9% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 194,996 shares of the company's stock after selling 45,367 shares during the period. Candriam S.C.A. owned 0.36March 7, 2025 | marketbeat.com4,123 Shares in Arcellx, Inc. (NASDAQ:ACLX) Acquired by SBI Securities Co. Ltd.SBI Securities Co. Ltd. bought a new position in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 4,123 shares of the company's stock, valued at appMarch 6, 2025 | marketbeat.comStifel Nicolaus Reaffirms Their Buy Rating on Arcellx Inc (ACLX)March 4, 2025 | markets.businessinsider.comWe're Not Worried About Arcellx's (NASDAQ:ACLX) Cash BurnMarch 3, 2025 | finance.yahoo.comEvercore ISI Reaffirms Their Buy Rating on Arcellx Inc (ACLX)March 3, 2025 | markets.businessinsider.comHC Wainwright Predicts Arcellx's Q1 Earnings (NASDAQ:ACLX)Arcellx, Inc. (NASDAQ:ACLX - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Arcellx in a note issued to investors on Friday, February 28th. HC Wainwright analyst E. Bodnar anticipates that the company will post earnings of ($March 3, 2025 | marketbeat.comArcellx (NASDAQ:ACLX) Trading 6.6% Higher - Here's WhyArcellx (NASDAQ:ACLX) Trading Up 6.6% - Time to Buy?March 1, 2025 | marketbeat.comArcellx Reports Promising 2024 Financial and Clinical ProgressFebruary 28, 2025 | tipranks.comArcellx (NASDAQ:ACLX) Posts Earnings Results, Misses Estimates By $0.24 EPSArcellx (NASDAQ:ACLX - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.87) earnings per share for the quarter, missing the consensus estimate of ($0.63) by ($0.24). Arcellx had a negative net margin of 25.94% and a negative return on equity of 8.28%.February 28, 2025 | marketbeat.comArcellx Inc (ACLX) Receives a Buy from Morgan StanleyFebruary 28, 2025 | markets.businessinsider.comArcellx Inc (ACLX) Receives a Buy from Piper SandlerFebruary 28, 2025 | markets.businessinsider.comBarclays Sticks to Its Buy Rating for Arcellx Inc (ACLX)February 28, 2025 | markets.businessinsider.comArcellx reports FY24 EPS ($2.00), consensus ($1.50)February 27, 2025 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Arcellx Inc (ACLX) and PTC Therapeutics (PTCT)February 27, 2025 | markets.businessinsider.comArcellx, Inc. (NASDAQ:ACLX) Insider Rami Elghandour Sells 38,300 SharesArcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Rami Elghandour sold 38,300 shares of Arcellx stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $62.02, for a total value of $2,375,366.00. Following the completion of the sale, the insider now directly owns 149,186 shares in the company, valued at $9,252,515.72. This represents a 20.43 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.February 27, 2025 | marketbeat.comArcellx Provides Fourth Quarter and Year-End 2024 Financial Results and Business HighlightsFebruary 27, 2025 | businesswire.comRami Elghandour Sells 38,300 Shares of Arcellx, Inc. (NASDAQ:ACLX) StockFebruary 27, 2025 | insidertrades.comArcellx, Inc. (NASDAQ:ACLX) Director Kavita Patel Sells 1,500 SharesArcellx, Inc. (NASDAQ:ACLX - Get Free Report) Director Kavita Patel sold 1,500 shares of Arcellx stock in a transaction that occurred on Tuesday, February 25th. The stock was sold at an average price of $63.16, for a total transaction of $94,740.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.February 26, 2025 | marketbeat.comArcellx to Participate at the TD Cowen 45th Annual Health Care ConferenceFebruary 26, 2025 | finance.yahoo.comArcellx to Participate at the TD Cowen 45th Annual Health Care ConferenceFebruary 26, 2025 | businesswire.comArcellx, Inc. (NASDAQ:ACLX) Director Sells $94,740.00 in StockFebruary 26, 2025 | insidertrades.comState of New Jersey Common Pension Fund D Buys Shares of 23,966 Arcellx, Inc. (NASDAQ:ACLX)State of New Jersey Common Pension Fund D purchased a new position in Arcellx, Inc. (NASDAQ:ACLX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 23,966 shares of the company's stock, valued at approximatFebruary 26, 2025 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Insider Sells $647,787.45 in StockArcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Christopher Heery sold 10,155 shares of the business's stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $63.79, for a total transaction of $647,787.45. Following the completion of the sale, the insider now directly owns 37,486 shares in the company, valued at approximately $2,391,231.94. This trade represents a 21.32 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.February 25, 2025 | marketbeat.comChristopher Heery Sells 10,155 Shares of Arcellx, Inc. (NASDAQ:ACLX) StockFebruary 25, 2025 | insidertrades.comIs Arcellx, Inc. (ACLX) An Oversold Biotech Stock to Buy Now?February 24, 2025 | insidermonkey.comArcellx, Inc. (NASDAQ:ACLX) Receives Average Recommendation of "Buy" from BrokeragesShares of Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) have earned a consensus rating of "Buy" from the fifteen brokerages that are covering the stock, MarketBeat.com reports. Thirteen research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendationFebruary 24, 2025 | marketbeat.comIs Arcellx (ACLX) Poised to Capture Significant Market Share?February 20, 2025 | msn.comArcellx (ACLX) Expected to Announce Quarterly Earnings on WednesdayArcellx (NASDAQ:ACLX) will be releasing earnings before the market opens on Wednesday, February 26.February 19, 2025 | marketbeat.comShort Interest in Arcellx, Inc. (NASDAQ:ACLX) Increases By 9.1%Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) was the recipient of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 7,310,000 shares, a growth of 9.1% from the January 15th total of 6,700,000 shares. Currently, 18.0% of the shares of the stock are sold short. Based on an average daily volume of 615,800 shares, the short-interest ratio is currently 11.9 days.February 16, 2025 | marketbeat.comarcellx director kavita patel sells $96,854 in stockFebruary 5, 2025 | msn.comArcellx, Inc. (NASDAQ:ACLX) Director Sells $96,855.00 in StockArcellx, Inc. (NASDAQ:ACLX - Get Free Report) Director Kavita Patel sold 1,500 shares of the business's stock in a transaction dated Tuesday, February 4th. The shares were sold at an average price of $64.57, for a total transaction of $96,855.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.February 4, 2025 | marketbeat.comArcellx (NASDAQ:ACLX) Trading Down 5.4% - Here's What HappenedArcellx (NASDAQ:ACLX) Trading Down 5.4% - Should You Sell?February 3, 2025 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Short Interest UpdateArcellx, Inc. (NASDAQ:ACLX - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 5,810,000 shares, an increase of 6.6% from the December 31st total of 5,450,000 shares. Currently, 14.3% of the shares of the company are short sold. Based on an average trading volume of 601,000 shares, the days-to-cover ratio is currently 9.7 days.February 2, 2025 | marketbeat.comMoody Aldrich Partners LLC Lowers Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX)Moody Aldrich Partners LLC cut its stake in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 60.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,683 shares of the company's stock after selling 16,122 shares during the quJanuary 30, 2025 | marketbeat.com Remove Ads Get Arcellx News Delivered to You Automatically Sign up to receive the latest news and ratings for ACLX and its competitors with MarketBeat's FREE daily newsletter. Email Address ACLX Media Mentions By Week ACLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACLX News Sentiment▼1.330.61▲Average Medical News Sentiment ACLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACLX Articles This Week▼25▲ACLX Articles Average Week Remove Ads Get Arcellx News Delivered to You Automatically Sign up to receive the latest news and ratings for ACLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SMMT News Today ITCI News Today GMAB News Today RDY News Today MRNA News Today VTRS News Today ASND News Today QGEN News Today ROIV News Today LNTH News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACLX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcellx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcellx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACLX Stock Free ACLX Stock Alerts